NCT02674243View on ClinicalTrials.gov

Efficacy of Iodopovidone Versus Talc in Palliative Malignant Pleural Effusion

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Malignant Pleural Effusion
Interventions
DRUG

Iodopovidone solution

In this group, iodopovidone solution will be used as pleurodesis substance

DRUG

Talc

In this group, Talc will be used as pleurodesis substance

Trial Locations (1)

50200

Department of surgery, Faculty of medicine, Chiang Mai University Hospital, Chiang Mai

All Listed Sponsors
lead

Chiang Mai University

OTHER

NCT02674243 - Efficacy of Iodopovidone Versus Talc in Palliative Malignant Pleural Effusion | Biotech Hunter | Biotech Hunter